Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Abstract:
      Cartography Biosciences, Inc., an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its Board of Directors since it was founded in 2014. [ABSTRACT FROM PUBLISHER]